JT
OCUL icon

Jupiter Topco’s Ocular Therapeutix OCUL Stock Holding History

Jupiter Topco’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$672K Buy
+68,500
New +$621K ﹤0.01% 1966

Other funds holding OCUL

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Jupiter Topco's OCUL Position: Q2 2026 in Review

Jupiter Topco opened a new position in Ocular Therapeutix (OCUL) in Q2 2026: 68,500 shares worth $672K. The stake represents ﹤0.01% of the portfolio and ranks #1966 among its holdings.

237 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Jupiter Topco held 68,500 shares of Ocular Therapeutix worth $672K as of Q2 2026.
  • Ocular Therapeutix was a new Jupiter Topco position in Q2 2026.
  • Ocular Therapeutix made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #1966 holding.
  • 237 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.